Logo image of SBNY

SIGNATURE BANK (SBNY) Stock Fundamental Analysis

USA - NASDAQ:SBNY - US82669G1040 - Common Stock

70 USD
-20.76 (-22.87%)
Last: 3/10/2023, 8:00:02 PM
69.62 USD
-0.38 (-0.54%)
Pre-Market: 3/13/2023, 8:49:01 AM
Fundamental Rating

5

Overall SBNY gets a fundamental rating of 5 out of 10. We evaluated SBNY against 392 industry peers in the Banks industry. There are concerns on the financial health of SBNY while its profitability can be described as average. SBNY is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

SBNY had positive earnings in the past year.
SBNY had a positive operating cash flow in the past year.
Of the past 5 years SBNY 4 years were profitable.
Of the past 5 years SBNY 4 years had a positive operating cash flow.
SBNY Yearly Net Income VS EBIT VS OCF VS FCFSBNY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M

1.2 Ratios

SBNY has a Return On Assets (1.11%) which is comparable to the rest of the industry.
SBNY has a Return On Equity of 16.54%. This is amongst the best in the industry. SBNY outperforms 84.57% of its industry peers.
Industry RankSector Rank
ROA 1.11%
ROE 16.54%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SBNY Yearly ROA, ROE, ROICSBNY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2 4 6 8 10

1.3 Margins

SBNY has a better Profit Margin (49.26%) than 98.94% of its industry peers.
SBNY's Profit Margin has improved in the last couple of years.
SBNY does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 49.26%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y5.51%
PM growth 5Y5.73%
GM growth 3YN/A
GM growth 5YN/A
SBNY Yearly Profit, Operating, Gross MarginsSBNY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 10 20 30 40

More info and screens

3

2. Health

2.1 Basic Checks

SBNY does not have a ROIC to compare to the WACC, probably because it is not profitable.
SBNY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SBNY Yearly Shares OutstandingSBNY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M 50M
SBNY Yearly Total Debt VS Total AssetsSBNY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 20B 40B 60B 80B 100B

2.2 Solvency

The Debt to FCF ratio of SBNY is 0.58, which is an excellent value as it means it would take SBNY, only 0.58 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.58, SBNY belongs to the top of the industry, outperforming 88.03% of the companies in the same industry.
A Debt/Equity ratio of 0.07 indicates that SBNY is not too dependend on debt financing.
SBNY has a better Debt to Equity ratio (0.07) than 76.06% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 0.58
Altman-Z N/A
ROIC/WACCN/A
WACC7.92%
SBNY Yearly LT Debt VS Equity VS FCFSBNY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2B 4B 6B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
SBNY Yearly Current Assets VS Current LiabilitesSBNY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M 1B

More info and screens

6

3. Growth

3.1 Past

SBNY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 41.94%, which is quite impressive.
SBNY shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.26% yearly.
SBNY shows a strong growth in Revenue. In the last year, the Revenue has grown by 39.46%.
The Revenue has been growing by 10.96% on average over the past years. This is quite good.
EPS 1Y (TTM)41.94%
EPS 3Y17.61%
EPS 5Y15.26%
EPS Q2Q%43.56%
Revenue 1Y (TTM)39.46%
Revenue growth 3Y14.04%
Revenue growth 5Y10.96%
Sales Q2Q%40.1%

3.2 Future

SBNY is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.56% yearly.
The Revenue is expected to grow by 10.98% on average over the next years. This is quite good.
EPS Next Y42.69%
EPS Next 2Y-0.32%
EPS Next 3Y2.56%
EPS Next 5YN/A
Revenue Next Year36.38%
Revenue Next 2Y12.21%
Revenue Next 3Y10.98%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
SBNY Yearly Revenue VS EstimatesSBNY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B
SBNY Yearly EPS VS EstimatesSBNY Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

More info and screens

8

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 3.54, which indicates a rather cheap valuation of SBNY.
SBNY's Price/Earnings ratio is rather cheap when compared to the industry. SBNY is cheaper than 94.68% of the companies in the same industry.
SBNY is valuated cheaply when we compare the Price/Earnings ratio to 27.70, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 4.69, the valuation of SBNY can be described as very cheap.
SBNY's Price/Forward Earnings ratio is rather cheap when compared to the industry. SBNY is cheaper than 91.76% of the companies in the same industry.
SBNY is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.15, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 3.54
Fwd PE 4.69
SBNY Price Earnings VS Forward Price EarningsSBNY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

82.18% of the companies in the same industry are more expensive than SBNY, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 3.56
EV/EBITDA N/A
SBNY Per share dataSBNY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

SBNY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.08
PEG (5Y)0.23
EPS Next 2Y-0.32%
EPS Next 3Y2.56%

More info and screens

3

5. Dividend

5.1 Amount

SBNY has a Yearly Dividend Yield of 2.19%. Purely for dividend investing, there may be better candidates out there.
The stock price of SBNY dropped by -40.96% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 3.59, SBNY is paying slightly less dividend.
SBNY's Dividend Yield is comparable with the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 2.19%

5.2 History

SBNY has been paying a dividend for over 5 years, so it has already some track record.
SBNY has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years4
SBNY Yearly Dividends per shareSBNY Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 0.5 1 1.5 2

5.3 Sustainability

13.87% of the earnings are spent on dividend by SBNY. This is a low number and sustainable payout ratio.
DP13.87%
EPS Next 2Y-0.32%
EPS Next 3Y2.56%
SBNY Yearly Income VS Free CF VS DividendSBNY Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M
SBNY Dividend Payout.SBNY Dividend Payout, showing the Payout Ratio.SBNY Dividend Payout.PayoutRetained Earnings

More info and screens

SIGNATURE BANK

NASDAQ:SBNY (3/10/2023, 8:00:02 PM)

Premarket: 69.62 -0.38 (-0.54%)

70

-20.76 (-22.87%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)01-17 2023-01-17/bmo
Earnings (Next)04-17 2023-04-17/bmo
Inst Owners0.65%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.40B
Analysts78.26
Price Target155.04 (121.49%)
Short Float %1.49%
Short Ratio0.51
Dividend
Industry RankSector Rank
Dividend Yield 2.19%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP13.87%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.55%
Min EPS beat(2)0.89%
Max EPS beat(2)2.2%
EPS beat(4)4
Avg EPS beat(4)3.99%
Min EPS beat(4)0.89%
Max EPS beat(4)7.83%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.29%
Min Revenue beat(2)-4.88%
Max Revenue beat(2)-1.7%
Revenue beat(4)1
Avg Revenue beat(4)-1.8%
Min Revenue beat(4)-4.88%
Max Revenue beat(4)1.59%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.22%
PT rev (3m)-27.03%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.58%
EPS NY rev (1m)-1.16%
EPS NY rev (3m)-1.16%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.93%
Revenue NY rev (1m)-0.76%
Revenue NY rev (3m)-0.76%
Valuation
Industry RankSector Rank
PE 3.54
Fwd PE 4.69
P/S 1.71
P/FCF 3.56
P/OCF 3.43
P/B 0.57
P/tB 0.57
EV/EBITDA N/A
EPS(TTM)19.8
EY28.29%
EPS(NY)14.93
Fwd EY21.34%
FCF(TTM)19.67
FCFY28.1%
OCF(TTM)20.43
OCFY29.18%
SpS41.03
BVpS122.21
TBVpS122.21
PEG (NY)0.08
PEG (5Y)0.23
Profitability
Industry RankSector Rank
ROA 1.11%
ROE 16.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 49.26%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y5.51%
PM growth 5Y5.73%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 0.58
Debt/EBITDA N/A
Cap/Depr 203.47%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 97.33%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC7.92%
ROIC/WACCN/A
Cap/Depr(3y)162.03%
Cap/Depr(5y)151.52%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)129.62%
Profit Quality(5y)130.1%
High Growth Momentum
Growth
EPS 1Y (TTM)41.94%
EPS 3Y17.61%
EPS 5Y15.26%
EPS Q2Q%43.56%
EPS Next Y42.69%
EPS Next 2Y-0.32%
EPS Next 3Y2.56%
EPS Next 5YN/A
Revenue 1Y (TTM)39.46%
Revenue growth 3Y14.04%
Revenue growth 5Y10.96%
Sales Q2Q%40.1%
Revenue Next Year36.38%
Revenue Next 2Y12.21%
Revenue Next 3Y10.98%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y42.55%
FCF growth 3Y9.8%
FCF growth 5Y9.09%
OCF growth 1Y40.94%
OCF growth 3Y10.52%
OCF growth 5Y9.26%